NCT00739934 Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection Status COMPLETED Phase PHASE2
NCT00739739 An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis Status COMPLETED Phase PHASE2
NCT00738738 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD) Status WITHDRAWN Phase PHASE3
NCT00737113 Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant Status TERMINATED Phase PHASE1
NCT00736528 A Phase I, Multiple Dose Study of PF-04447943 in Healthy Elderly Volunteers Status TERMINATED Phase PHASE1
NCT00735904 Trial Of AG-013736, Cisplatin, And Gemcitabine For Patients With Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00735267 A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD) Status TERMINATED Phase PHASE3
NCT00735072 Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure Status COMPLETED Phase PHASE4
NCT00734123 Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases. Status UNKNOWN Phase PHASE4
NCT00733642 Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE1
NCT00732992 A Safety Study Of Sunitinib In Combination With Pemetrexed In Patients With Advanced Solid Malignancies Status COMPLETED Phase PHASE1
NCT00731562 An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation Status COMPLETED Phase PHASE1
NCT00730990 A Phase I, Healthy Volunteer Positron Emission Tomography Study Status COMPLETED Phase PHASE1
NCT00730665 Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD) Status TERMINATED Phase PHASE2
NCT00730535 Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients Status COMPLETED Phase PHASE4